Advertisement

Topics

Mylan to commercialize next-gen TB drug in developing countries

07:27 EDT 24 Aug 2017 | thePharmaLetter

Japan’s Otsuka Pharmaceutical has sold commercialization rights to Netherlands-incorporated Mylan for…

Original Article: Mylan to commercialize next-gen TB drug in developing countries

NEXT ARTICLE

More From BioPortfolio on "Mylan to commercialize next-gen TB drug in developing countries"

Advertisement
Quick Search
Advertisement
Advertisement